Abstract
Importance Torque teno virus positivity in the aqueous humor of uveitis patients could be associated with systemic immunodeficiency.
Objective We explored the correlation between the presence of torque teno virus in the aqueous humor of uveitis patients and clinical information, including immunodeficiency history.
Design This was a retrospective, cross-sectional study.
Setting All participants were recruited at Nagoya University Hospital, Tokyo Medical University Hospital, or Yokkaichi Municipal Hospital between April 2017 and March 2022.
Participants The participants were 58 uveitis patients with a suspected infectious etiology and 24 controls with cataract or age-related macular degeneration.
Main Outcomes and Measures We used quantitative polymerase chain reaction to test all subjects for torque teno virus and multiplex polymerase chain reaction to test uveitis subjects for common ocular pathogens. When possible, both serum and aqueous humor samples were tested. Ocular torque teno virus positivity was compared with age, sex, and a history of systemic immunodeficiency with logistic analysis.
Results Torque teno virus positivity was found in 7 of 31 cases (23%) with herpetic uveitis, 3 of 27 cases (11%) with nonherpetic uveitis, and 0 of 24 controls (0%). Among patients with herpes infection, positivity for torque teno virus was found in 3 of 7 patients (43%) with cytomegalovirus retinitis, 1 of 12 (8%) patients with iridocyclitis, 1 of 7 patients (14%) with acute retinal necrosis, and 2 of 4 patients (50%) with Epstein–Barr virus–related uveitis. Cytomegalovirus retinitis patients showed a significantly higher rate of ocular torque teno virus infection than controls (P = .008). Serum analysis revealed torque teno virus positivity in 9 of 10 cases (90%) with uveitis and in all 8 controls (100%). Age- and gender-adjusted logistic analysis revealed a correlation between ocular torque teno virus positivity and systemic immunodeficiency (P = .01), but no correlations between ocular torque teno virus and age, gender, or viral pathogenic type.
Conclusion and Relevance This study found that positivity for ocular torque teno virus was correlated with a clinical history of systemic immunodeficiency. This suggests that ocular torque teno virus is a biomarker of systemic immunity.
Question What is the correlation between torque teno virus (TTV) in the aqueous humor of patients with uveitis and the clinical characteristics of these patients?
Findings In this retrospective, cross-sectional study that included 82 patients, ocular TTV was found to be present in 39% of uveitis patients with underlying immunodeficiency and 8% of patients without underlying immunodeficiency; these findings showed statistical significance.
Meaning In patients with uveitis, the presence of ocular TTV may represent systemic immunodeficiency.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KMN had financial support from Nippon Kayaku Co., Ltd. for submitted work; HU has received research grants from Nippon Kayaku Co., Ltd. and honoraria for presentations from Amgen K. K. and Otsuka Pharmaceutical Co.,Ltd. KMN has received honorarium for presentations and support for attending a meeting and travel from AbbVie Inc.; no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This study was funded by a grant from the Japan Society for the Promotion of Science KAKENHI, grant number 20K09765 (Koji M Nishiguchi), 22K20958 (Ai Fujita Sajiki).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We received approval from the Ethics Review Committee of Nagoya University Graduate School of Medicine.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Co–first author
This study was presented in part at the 126th Annual Meeting of the Japanese Ophthalmological Society in April 2022 and will be presented at the 76th Annual Congress of Japan Clinical Ophthalmology in October 2022.
Data Availability
All data produced in the present work are contained in the manuscript.
